ALTSCHULLER Susan 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Jan 23, 2024
Insider Transaction Report
Form 4
ALTSCHULLER Susan
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2024-01-19+81,065→ 81,065 total→ Common Stock (81,065 underlying)
Footnotes (1)
- [F1]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments on each of January 19, 2025, January 19, 2026, January 19, 2027 and January 19, 2028, subject to the Reporting Person's continued service on each such vesting date.